BRIEF published on 11/22/2024 at 07:35, 10 hours 44 minutes ago Pyrum Innovations AG Reports First Nine Months of 2024 Results Liquidity Financial Report Sales Growth Investment 2024 Forecast
BRIEF published on 11/22/2024 at 07:35, 10 hours 44 minutes ago Cyan AG Enters Belgian Market with Orange Belgium Partnership Cybersecurity Digital Security International Expansion Cyan AG Orange Belgium
BRIEF published on 11/22/2024 at 07:35, 10 hours 44 minutes ago All for One Group SE Launches EUR 7 Million Share Buyback Programme Share Buyback Treasury Shares Stock Market All For One Group EUR 7 Million
BRIEF published on 11/22/2024 at 07:28, 10 hours 50 minutes ago Optimus BidCo AG Acquires Majority Stake in OTRS AG IT Service Management OTRS AG Acquisition Optimus BidCo AG Easyvista SAS EUR 17 Per Share
BRIEF published on 11/22/2024 at 07:05, 11 hours 14 minutes ago Vita 34 Reports Revenue Growth and Cash Increase in Q3 2024 Revenue Growth Cash Flow Profitability Market Expansion Cell Banking
BRIEF published on 11/22/2024 at 07:05, 11 hours 14 minutes ago SoftwareOne Finalizes CHF 70 Million Share Buyback Initiative Share Buyback Shareholder Approval SoftwareOne SIX Swiss Exchange Cloud Solutions
BRIEF published on 11/22/2024 at 07:05, 11 hours 14 minutes ago First Berlin Raises beaconsmind AG Price Target Amid Strategic Acquisitions Acquisitions Price Target SaaS Solutions Beaconsmind AG First Berlin
BRIEF published on 11/22/2024 at 06:50, 11 hours 29 minutes ago Komax Group's Strategic Progress Amidst Market Challenges Operational Efficiency Market Expansion Revenue Targets China Market Komax Strategy
BRIEF published on 11/22/2024 at 00:05, 18 hours 14 minutes ago Gratomic Provides Update on Aukam Graphite Mine and Board Changes Graphite Supply Gratomic Aukam Graphite Mine Hermanus Manuel Silver Kobus La Grange
BRIEF published on 11/21/2024 at 22:10, 20 hours 9 minutes ago Protagonist Therapeutics Nominates PN-881 for Immune-Mediated Skin Disorders Protagonist Therapeutics IL-17 Antagonist PN-881 Skin Diseases Phase I Trials
Published on 11/22/2024 at 16:00, 2 hours 19 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 2 hours 24 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 3 hours 4 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 3 hours 34 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 3 hours 49 minutes ago Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best
Published on 11/22/2024 at 16:55, 1 hour 23 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 2 hours 19 minutes ago Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 2 hours 19 minutes ago AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/21/2024 at 06:58, 1 day 11 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 22 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
